05/15/2025 3:39 PM | Paradigm Biocapital Advisors LP (Filed by) Pliant Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025 9:45 AM | Pliant Therapeutics (Subject) PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025 3:13 PM | Pliant Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2025 3:17 PM | Pliant Therapeutics (Filer)
| Form DEF 14A | |
04/23/2025 3:19 PM | Pliant Therapeutics (Filer)
| Form DEFA14A | |
04/10/2025 3:30 PM | Pliant Therapeutics (Filer)
| Form PRE 14A | |
03/13/2025 7:49 AM | Pliant Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2025 7:05 AM | Pliant Therapeutics (Filer)
| Form 8-A12B | |
03/10/2025 4:24 PM | Pliant Therapeutics (Subject) TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13D | |
03/07/2025 9:01 AM | FMR LLC (Filed by) Pliant Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/03/2025 3:18 PM | Pliant Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for PLRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
02/14/2025 7:01 PM | Pliant Therapeutics (Subject) Redmile Group, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025 8:00 AM | Pliant Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/10/2025 6:01 AM | Pliant Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/27/2025 5:14 PM | Cheung Lily (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 5:01 PM | Cummings Keith Lamont (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 5:04 PM | Lefebvre Eric (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 5:07 PM | Hull Hans (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 5:10 PM | Ouimette Mike (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 4:58 PM | Coulie Bernard (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 4:55 PM | Ouimette Mike (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 4:58 PM | Cheung Lily (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:00 PM | Lefebvre Eric (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:02 PM | Hull Hans (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:05 PM | Cummings Keith Lamont (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:07 PM | Coulie Bernard (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 3:23 PM | Ouimette Mike (Reporting) Pliant Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 8:00 PM | Pliant Therapeutics (Subject) Redmile Group, LLC (Filed by)
| Form SC 13G | |
11/12/2024 10:53 AM | Laurion Capital Management LP (Filed by) Pliant Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024 4:34 PM | Paradigm Biocapital Advisors LP (Filed by) Pliant Therapeutics (Subject)
| Form SC 13G | |
09/27/2024 3:11 PM | Pliant Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 3:13 PM | Pliant Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024 10:54 AM | Pliant Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 5:37 PM | Cummings Keith Lamont (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 5:41 PM | Hull Hans (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 5:45 PM | Lefebvre Eric (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 5:15 PM | Ouimette Mike (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 5:22 PM | Coulie Bernard (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 4:01 PM | Lefebvre Eric (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 3:47 PM | Coulie Bernard (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 3:54 PM | Cummings Keith Lamont (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Elon just did WHAT!? (Ad) As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC.
Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever.
But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs…
Paving the way for Elon Musk's secret master plan. Click here to see how to claim your stake before they launch to avoid missing out. |
07/11/2024 3:41 PM | Ouimette Mike (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:15 PM | Curnutte John T (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:15 PM | Bruhn Suzanne Louise (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:15 PM | CROWELL GAYLE A (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:15 PM | Cline Darren S (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:15 PM | Pliant Therapeutics (Issuer) Shah Smital (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:16 PM | Pliant Therapeutics (Issuer) PYOTT DAVID E I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:16 PM | Huh Hoyoung (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:16 PM | Knobil Katharine (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:16 PM | MCCOURT Thomas A (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:57 PM | Krognes Steve E. (Reporting) Pliant Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:52 PM | Krognes Steve E. (Reporting) Pliant Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |